| Completed | An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclero Systemic Sclerosis | Phase 2 | 2022-04-20 |
| Withdrawn | A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodyna Psoriasis | Phase 2 | 2019-06-01 |
| Unknown | Topical Ionic Contra-Viral Therapy in Actinic Keratosis Actinic Keratosis | Phase 2 | 2018-10-22 |
| Unknown | Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis Seborrheic Dermatitis | Phase 2 | 2018-10-22 |
| Completed | A Study to Evaluate the Safety and Efficacy of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts | Phase 3 | 2017-10-30 |
| Terminated | ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients HPV-Induced Genital Lesions | Phase 2 | 2017-10-05 |
| Completed | Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2017-03-08 |
| Completed | Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers Healthy | Phase 1 | 2017-02-06 |
| Completed | A Phase 3 Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Old Cutaneous Common Warts | Phase 3 | 2017-01-01 |
| Completed | Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts Condylomata Acuminata (External) | Phase 2 | 2016-07-01 |
| Completed | Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle Rosacea | Phase 3 | 2015-12-01 |
| Completed | Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN Usual Type Vulval Intraepithelial Neoplasia (uVIN) | Phase 2 | 2015-11-01 |
| Completed | Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle Rosacea | Phase 3 | 2015-10-01 |
| Completed | Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel Rosacea | Phase 3 | 2015-10-01 |
| Completed | A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects Acne Vulgaris | Phase 2 | 2015-10-01 |
| Completed | Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2015-05-01 |
| Completed | A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts. Cutaneous Warts | Phase 2 | 2015-01-01 |
| Completed | Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris Acne Vulgaris | Phase 2 | 2014-04-01 |
| Completed | First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts Cutaneous Warts | Phase 1 / Phase 2 | 2014-03-01 |
| Completed | A 21 Day Pharmacokinetics Study in Papulopustular Rosacea Papulopustular Rosacea | Phase 1 | 2014-01-01 |
| Completed | Open-label Study of ASP2151 in Herpes Simplex Patients Herpes Simplex | Phase 3 | 2013-11-01 |
| Completed | Phase III Study of ASP2151 in Herpes Simplex Patients Herpes Simplex | Phase 3 | 2013-08-01 |
| Completed | Phase III Study of ASP2151 in Herpes Zoster Patients Herpes Zoster | Phase 3 | 2013-08-01 |
| Completed | A Twelve Week Safety and Efficacy Study in Rosacea Papulopustular Rosacea | Phase 2 | 2013-03-01 |
| Completed | Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients Plaque Psoriasis | Phase 2 | 2011-02-01 |
| Completed | Study to Investigate the Efficacy and the Safety of M518101 in Psoriasis Patients Plaque Psoriasis | Phase 2 | 2009-07-01 |
| Completed | Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2008-08-01 |